Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haibo Qiu

Showing results (371-380 of 387) with videos related to

Pageof 39
Sort By:
Intensive Care Medicine|February 10, 2023
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort studyAlexis Tabah, Niccolò Buetti, Quentin Staiquly, et al.
Intensive Care Medicine|October 10, 2023
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trialRon Wald, Stephane Gaudry, Bruno R da Costa, et al.
Scientific Reports|August 21, 2019
A novel bispecific antibody platform to direct complement activity for efficient lysis of target cellsJonathan W Cruz, Ermelinda Damko, Bhavika Modi, et al.
Intensive Care Medicine|December 12, 2018
Early extubation followed by immediate noninvasive ventilation vs. standard extubation in hypoxemic patients: a randomized clinical trialRosanna Vaschetto, Federico Longhini, Paolo Persona, et al.
Cancer|December 9, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trialJun Zhang, Yanqiao Zhang, Haibo Qiu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilliMei Zeng, Jun Xia, Zhiyong Zong, et al.
The Lancet. Respiratory Medicine|June 19, 2017
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort studyJohn G Laffey, Fabiana Madotto, Giacomo Bellani, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2023
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in ChinaJian Li, Jun Zhang, Yanqiao Zhang, et al.
The New England Journal of Medicine|July 16, 2020
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury, , , et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2023
A New Global Definition of Acute Respiratory Distress SyndromeMichael A Matthay, Yaseen Arabi, Alejandro C Arroliga, et al.
Pageof 39

Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
Intensive Care Medicine|February 10, 2023
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort studyAlexis Tabah, Niccolò Buetti, Quentin Staiquly, et al.
Intensive Care Medicine|October 10, 2023
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trialRon Wald, Stephane Gaudry, Bruno R da Costa, et al.
Scientific Reports|August 21, 2019
A novel bispecific antibody platform to direct complement activity for efficient lysis of target cellsJonathan W Cruz, Ermelinda Damko, Bhavika Modi, et al.
Intensive Care Medicine|December 12, 2018
Early extubation followed by immediate noninvasive ventilation vs. standard extubation in hypoxemic patients: a randomized clinical trialRosanna Vaschetto, Federico Longhini, Paolo Persona, et al.
Cancer|December 9, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trialJun Zhang, Yanqiao Zhang, Haibo Qiu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilliMei Zeng, Jun Xia, Zhiyong Zong, et al.
The Lancet. Respiratory Medicine|June 19, 2017
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort studyJohn G Laffey, Fabiana Madotto, Giacomo Bellani, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2023
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in ChinaJian Li, Jun Zhang, Yanqiao Zhang, et al.
The New England Journal of Medicine|July 16, 2020
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury, , , et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2023
A New Global Definition of Acute Respiratory Distress SyndromeMichael A Matthay, Yaseen Arabi, Alejandro C Arroliga, et al.
Pageof 39